Autoimmunity and coxsackievirus infection in primary Sjögren's syndrome

Annals of the New York Academy of Sciences

Volumn 1050, Issue , 2005, Pages 389-396

  Triantafyllopoulou, Antigoni ^a,b   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Coxsackieviruses; Epithelial cell activation; Sj gren's syndrome

Indexed keywords

AUTOIMMUNITY; CELL ACTIVATION; CLINICAL FEATURE; CONFERENCE PAPER; COXSACKIE VIRUS; COXSACKIE VIRUS INFECTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; EPITHELIUM CELL; EXOCRINE GLAND; HUMAN; IMMUNOPATHOLOGY; PHENOTYPE; SALIVARY GLAND; SJOEGREN SYNDROME;

COXSACKIEVIRUS;

EID: 23744462284     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1313.090     Document Type: Conference Paper

References (49)

1. TAPINOS, N.I., M. POLIHRONIS, A.G. TZIOUFAS et al. 1999. Sjögren's syndrome: autoimmune epithelitis. Adv. Exp. Med. Biol. 455: 127-134.
2. MATSUMOTO, I., K. TSUBOTA, Y. SATAKE et al. 1996. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome. J. Clin. Invest. 97(8): 1969-1977.
3. SUMIDA, T., T. NAMEKAWA, T. MAEDA et al. 1996. New T-cell epitope of Ro/SSA 52 kDa protein in labial salivary glands from patients with Sjögren's syndrome. Lancet 348: 1667.
4. STOTT, D., F. HIEPE, M. HUMMEL et al. 1998. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. J. Clin. Invest. 102(5): 938-946.
5. SALOMONSSON, S., M.V. JONSSON, K. SKARSTEIN et al. 2003. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum. 48(11): 3187-3201.
6. XANTHOU, G., M. POLIHRONIS, A.G. TZIOUFAS et al. 2001. "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients. Arthritis Rheum. 44(2): 408-418.
7. KAPSOGEORGOU, E., H.M. MOUTSOPOULOS & M.N. MANOUSSAKIS. 2001. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. J. Immunol. 166: 3107-3113.
8. PUJOL-BORRELL, R., I. TODD, M. LONDEI et al. 1986. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic β cells in type I diabetes. Mol. Biol. Med. 3: 159.
9. HANAFUSA, T., R. PUJOL-BORRELL, L. CHIOVATO et al. 1983. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 2: 1111.
10. MARKMANN, J., D. LO, A. NAJI et al. 1988. Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature 336: 476.
11. FAN, X., S.E. CROWE, S. BEHAR et al. 1998. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J. Exp. Med. 187(10): 1659-1669.
12. FAN, X., H. GUNASENA, Z. CHENG et al. 2000. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J. Immunol. 165(4): 1918-1924.
13. ZANONE, M., E. FAVARO, P. CONALDI et al. 2003. Persistent infection of human microvascular endothelial cells by coxsackie B viruses induces increased expression of adhesion molecules. J. Immunol. 171: 438-446.
14. HADDAD, J., P. DENY, C. GUNZ-GOTHEIL et al. 1992. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339: 321-323.
15. OHYAMA, Y., S. NAKAMURA, H. HARA et al. 1998. Accumulation of human T lymphotropic virus type 1-infected T cells in the salivary glands of patients with human T lymphotropic virus type 1-associated Siögren's syndrome. Arthritis Rheum. 41(11): 1972-1978.
16. TALAL, N., M.J. DAUPHINEE, H. DANG et al. 1990. Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome. Arthritis Rheum. 33: 774-781.
17. KORDOSSIS, T., S. PAIKOS, K. ARONI et al. 1998. Prevalence of Sjögren's-like syndrome in a cohort of HIV-1 positive patients: descriptive pathology and immunopathology. Br. J. Rheumatol. 37: 691-695.
18. ARRIETA, J., E. RODRIGUEZ-INIGO, N. ORTIZ-MOVILLA et al. 2001. In situ detection of hepatitis C virus RNA in salivary glands. Am. J. Pathol. 158: 259-264.
19. SCOTT, C.A., C. AVELLINI, L. DESINAN et al. 1997. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison with Sjögren's syndrome. Histopathology 30: 41-48.
20. RACANELLI, V., D. SANSONNO, C. PICOLLI et al. 2001. Molecular characterization of B clonal expansions in the liver of chronically hepatitis C virus-infected patients. J. Immunol. 167: 21-29.
21. TRIANTAFYLLOPOULOU, A., N. TAPINOS & H.M. MOUTSOPOULOS. 2004. Evidence for coxsackievirus infection in primary Sjögren's syndrome. Arthritis Rheum. 50(9): 2897-2902.
22. YOON, J.W., M. AUSTIN, T. ONODERA & A.L. NOTKINS. 1979. Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 300: 1173-1179.
23. JAECKEL, E., M. MANNS & M. VON HERRATH. 2002. Viruses and diabetes. Ann. N.Y. Acad. Sci. 958: 7-25.
24. BOCHAROV, E.F., I.P. SHORIN, I.A. SOLODOVNIKOVA et al. 1988. Diabetogenic properties of coxsackie A13 and coxsackie B4 viruses in experimental infection in mice. Vopr. Virusol. 33(4): 469-474.
25. ZHANG, H., Y LI, D.R. MCCLEAN et al. 2004. Detection of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: further evidence of enterovirus persistence in myocytes. Med. Microbiol. Immunol. (Berl.) 193(2/3): 109-114.
26. BOURLET, T., J. GHARBI, S. OMAR et al. 1998. Comparison of a rapid culture method combining an immunoperoxidase test and a group specific anti-VP1 monoclonal antibody with conventional virus isolation techniques for routine detection of enteroviruses in stools. J. Med. Virol. 54: 204-209.
27. ZHANG, H., Y. LI, T. PENG et al. 2000. Localization of enteroviral antigen in myocardium and other tissues from patients with heart muscle disease by an improved immunohistochemical technique. J. Histochem. Cytochem. 48: 579-584.
28. SAMUELSON, A., M. FORSGREN & M. SALLBEREG. 1995. Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody. Clin. Diagn. Lab. Immunol. 2: 385-386.
29. TRABELSI, A., F. GRATTARD, M. NEJMEDDINE et al. 1995. Evaluation of an enterovirus group-specific anti-VP1 monoclonal antibody, 5D8/1, in comparison with neutralization and PCR for rapid identification of enterovirus in cell culture. J. Clin. Microbiol. 33: 2454-2457.
30. YOUSEF, G.E., I.N. BROWN & J.F. MOWBRAY. 1987. Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody. Intervirology 28: 163-170.
31. FRISK, G., A.M. LINDBERG & H. DIDERHOLM. 1999. Persistence of coxsackievirus B4 infection in rhabdomyosarcoma cells for 30 months. Arch. Virol. 144: 2239-2245.
32. BRILOT, P., W. CHEHADEH, C. CHARLET-RENARD et al. 2002. Persistent infection of human thymic epithelial cells by coxsackievirus B4. J. Virol. 76(10): 5260-5265.
33. HARRATH, R., T. BOURLET, O. DELEZAY et al. 2005. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line. Submitted.
34. CHEHADEH, W., J. KERR-CONTE, F. PATTOU et al. 2000. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in cells. J. Virol. 74(21): 10153-10164.
35. LESLIE, K., R. BLAY, C. HAISH et al. 1989. Clinical and experimental aspects of viral myocarditis. Clin. Microbiol. Rev. 2(2): 191-203.
36. ANDREOLETTI, L., P. WATTRE, C. DECOENE et al. 1995. Detection of enterovirus-specific RNA sequences in explanted myocardium biopsy specimens from patients with dilated or ischemic cardiomyopathy. Clin. Infect. Dis. 21: 1315-1317.
37. HORWITZ, M., L. BRADLEY, J. HARBERTSON et al. 1998. Diabetes induced by coxsackievirus: initiation by bystander damage and not molecular mimickry. Nat. Med. 4(7): 781-785.
38. HORWITZ, M., A. ILIC, C. FINE et al. 2002. Presented antigen from damaged pancreatic cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J. Clin. Invest. 109: 79-87.
39. NEUMANN, D.A., N.R. ROSE, A.A. ANSARI et al. 1994. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. J. Immunol. 152: 343-350.
40. WOLFGRAM, L.J., K.W. BEISEL & N.R. ROSE. 1985. Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. J. Exp. Med. 161(5): 1112-1121.
41. HUBER, S.A. & P.A. LODGE. 1984. Coxsackievirus B-3 myocarditis in BALB/c mice: evidence for autoimmunity to myocyte antigens. Am. J. Pathol. 116(1): 21-29.
42. WESSELY, R., K. KLINGEL, L.F. SANTANA et al. 1998. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J. Clin. Invest. 102: 1444-1453.
43. BADORFF, C., N. BERKELY, S. MEHROTRA et al. 2000. Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue. J. Biol. Chem. 275(15): 11191-11197.
44. ANDERSON, D.R., J.E. WILSON, C.M. CARTHY et al. 1996. Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J. Virol. 70(7): 4632-4645.
45. KLINGEL, K., S. STEPHAN, M. SEUTER et al. 1996. Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J. Virol. 70(12): 8888-8895.
46. SHIROKI, K., T. ISOYAMA, S. KUGE et al. 1999. Intracellular redistribution of truncated La protein produced by poliovirus 3C pro-mediated cleavage. J. Virol. 73(3): 2193-2200.
47. TOPFER, F., T. GORDON & J. MCCLUSKEY. 1995. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc. Natl. Acad. Sci. USA 92: 875-879.
48. HUNZIKER, L., M. RECHER, A. MACPHERSON et al. 2003. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat. Immunol. 4(4): 343-349.
49. APPAY, V., J. ZAUNDERS, L. PAPAGNO et al. 2002. Characterization of CD4+ CTLs ex vivo. J. Immunol. 168: 5954-5958.